Germany's Eckert & Ziegler H1 net income rises, confirms FY view

Eckert & Ziegler SE

13/08/2026 06:56

Overview
Germany isotope components maker's H1 sales were flat yr/yr, adjusted EBIT declined nearly 6%
Net income for H1 rose about 5% to €22.4 mln
Company confirmed 2026 sales and EBIT guidance

Outlook
Eckert & Ziegler confirms 2026 sales forecast of around €320 mln
Company maintains 2026 EBIT before special items guidance at around €80 mln

Result Drivers
LICENSING REVENUE IMPACT - Co said group sales and earnings rose 4% and 9% respectively when excluding prior-year extraordinary licensing revenue, which was absent in 2026
MEDICAL SEGMENT GROWTH - Adjusted EBIT in Medical segment rose nearly 7% to €24.9 mln, with sales slightly above prior-year level; pharmaceutical radioisotopes remained key revenue driver
ISOTOPE PRODUCTS STABLE - Isotope Products segment sales were nearly unchanged yr/yr at €68.5 mln

Company press release: ID:nEQ5rHbCKa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Sales
 
EUR 149.30 mln
 
H1 EPS
 
EUR 0.36
 
H1 Net Income
 
EUR 22.40 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Eckert & Ziegler SE is €21.00, about 52.7% above its August 12 closing price of €13.75
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 18 three months ago

Reuters Recommended Reads
Aug 12 - Germany's Medios H1 profit hit by pricing pressure; to buy 74% of Caelo to expand API
Aug 11 - Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Aug 12 - Sweden's Magle Chemoswed Q2 revenue rises on improved production efficiencies

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)